🌿 How it works?
When you eat, your intestinal cells release GLP-1. It travels to your brain and activates receptors in the hypothalamus — the region that controls hunger and satiety. The result: you feel full faster, stay full longer, and your appetite decreases significantly. GLP-1 also slows how quickly your stomach empties, which keeps blood sugar stable after meals.
GLP-1 receptor agonists are synthetic versions of this hormone designed to stay active in your body much longer than the natural version, which breaks down within minutes.
GLP-1 receptor agonists are synthetic versions of this hormone designed to stay active in your body much longer than the natural version, which breaks down within minutes.
1️⃣ What the research shows
The clinical data on GLP-1 agonists is some of the strongest ever seen in obesity medicine. In landmark trials, participants using Semaglutide (the active ingredient in Ozempic and Wegovy) lost an average of 15–17% of their body weight over 68 weeks — results previously only seen with bariatric surgery. More recent research suggests some formulations may reach 20%+ average weight loss.
Beyond weight, GLP-1 agonists have shown meaningful benefits for cardiovascular health, blood sugar regulation in type 2 diabetes, and emerging research even suggests potential benefits for fatty liver disease and addiction behaviors.
Beyond weight, GLP-1 agonists have shown meaningful benefits for cardiovascular health, blood sugar regulation in type 2 diabetes, and emerging research even suggests potential benefits for fatty liver disease and addiction behaviors.
2️⃣ Who uses GLP-1 agonists
GLP-1 receptor agonists were originally developed for type 2 diabetes management. They are now prescribed for weight loss in people with obesity or weight-related health conditions. They are administered as weekly injections, and are available under brand names including Ozempic, Wegovy, and Rybelsus.
3️⃣ What to know before considering it
GLP-1 agonists are prescription medications — not supplements. They require medical supervision. Common side effects include nausea, vomiting, and gastrointestinal discomfort, particularly in the early weeks. These typically improve as the body adjusts. Rare but serious risks include pancreatitis and, in animal studies, thyroid tumors — though the relevance to humans is still being studied.
Stopping GLP-1 treatment without lifestyle changes often leads to weight regain, which is why protocol, nutrition, and ongoing support matter enormously alongside the medication itself.
✅ Ready to build a protocol around GLP-1? → See the True BioCare Membership
Stopping GLP-1 treatment without lifestyle changes often leads to weight regain, which is why protocol, nutrition, and ongoing support matter enormously alongside the medication itself.
✅ Ready to build a protocol around GLP-1? → See the True BioCare Membership